MIAMI, FL. JANUARY 3, 2019 – ArisGlobal, LLC, a leading provider of integrated cloud-based software solutions for life sciences, will present a session titled, “ArisGlobal Solution: Supporting Life Science Industry to Be Compliant with the New Regulation in China” at the upcoming 9th Asia Pharma R&D Leaders – Pharma & Healthcare to be held in Beijing from January 21-22, 2019.
Krishana Gopal Das, Head of Product Strategy, and Ye Zha, Executive Director, Greater China, ArisGlobal, will present the session, scheduled for January 21, 4:00 PM CST. Krishana and Ye will provide an overview of pharmacovigilance in China and the recent regulatory reforms made to achieve standards on par with leading health authorities.
“With the recent string of regulatory reforms and NMPA joining ICH, China is poised to catch up with the leading health authorities in bringing high-quality, low-cost, innovative solutions to its population and ensuring safe and effective use of medicinal products,” Krishana explained. “In addition to sharing an overview of pharmacovigilance in China, we will also share how drug manufacturers can comply with the new regulatory environment for drug safety in China using modern applications.”
ArisGlobal is a sponsor of this conference and will be exhibiting in booth #14. Attendees are welcome to visit and learn more about LifeSphere® MultiVigilance, the next-generation platform for individual case safety report (ICSR) intake powered by LifeSphere Nava – ArisGlobal’s cognitive computing engine.
Download ArisGlobal’s 2024 Industry Report 
